99 related articles for article (PubMed ID: 25987650)
1. Methods to assess an exercise intervention trial based on 3-level functional data.
Li H; Kozey Keadle S; Staudenmayer J; Assaad H; Huang JZ; Carroll RJ
Biostatistics; 2015 Oct; 16(4):754-71. PubMed ID: 25987650
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical functional data with mixed continuous and binary measurements.
Li H; Staudenmayer J; Carroll RJ
Biometrics; 2014 Dec; 70(4):802-11. PubMed ID: 25134936
[TBL] [Abstract][Full Text] [Related]
3. Three-part joint modeling methods for complex functional data mixed with zero-and-one-inflated proportions and zero-inflated continuous outcomes with skewness.
Li H; Staudenmayer J; Wang T; Keadle SK; Carroll RJ
Stat Med; 2018 Feb; 37(4):611-626. PubMed ID: 29052239
[TBL] [Abstract][Full Text] [Related]
4. Joint modelling of paired sparse functional data using principal components.
Zhou L; Huang JZ; Carroll RJ
Biometrika; 2008; 95(3):601-619. PubMed ID: 19396364
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal functional additive model with continuous proportional outcomes for physical activity data.
Li H; Kozey-Keadle S; Kipnis V; Carroll RJ
Stat (Int Stat Inst); 2016; 5(1):242-250. PubMed ID: 27904749
[TBL] [Abstract][Full Text] [Related]
6. Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.
Nguyen TT; Bazzoli C; Mentré F
Stat Med; 2012 May; 31(11-12):1043-58. PubMed ID: 21965170
[TBL] [Abstract][Full Text] [Related]
7. Penalized regression procedures for variable selection in the potential outcomes framework.
Ghosh D; Zhu Y; Coffman DL
Stat Med; 2015 May; 34(10):1645-58. PubMed ID: 25628185
[TBL] [Abstract][Full Text] [Related]
8. Classification of longitudinal data through a semiparametric mixed-effects model based on lasso-type estimators.
Arribas-Gil A; De la Cruz R; Lebarbier E; Meza C
Biometrics; 2015 Jun; 71(2):333-43. PubMed ID: 25639332
[TBL] [Abstract][Full Text] [Related]
9. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
[TBL] [Abstract][Full Text] [Related]
10. Subgroup analysis based on structured mixed-effects models for longitudinal data.
Shen J; Qu A
J Biopharm Stat; 2020 Jul; 30(4):607-622. PubMed ID: 32126871
[TBL] [Abstract][Full Text] [Related]
11. A Copula Approach to Joint Modeling of Longitudinal Measurements and Survival Times Using Monte Carlo Expectation-Maximization with Application to AIDS Studies.
Ganjali M; Baghfalaki T
J Biopharm Stat; 2015; 25(5):1077-99. PubMed ID: 25372017
[TBL] [Abstract][Full Text] [Related]
12. Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.
Retout S; Comets E; Samson A; Mentré F
Stat Med; 2007 Dec; 26(28):5162-79. PubMed ID: 17486667
[TBL] [Abstract][Full Text] [Related]
13. On model selections for repeated measurement data in clinical studies.
Zou B; Jin B; Koch GG; Zhou H; Borst SE; Menon S; Shuster JJ
Stat Med; 2015 May; 34(10):1621-33. PubMed ID: 25645442
[TBL] [Abstract][Full Text] [Related]
14. Profile clustering in clinical trials with longitudinal and functional data methods.
Gong H; Xun X; Zhou Y
J Biopharm Stat; 2019; 29(3):541-557. PubMed ID: 30810454
[TBL] [Abstract][Full Text] [Related]
15. Semiparametric models for missing covariate and response data in regression models.
Chen Q; Ibrahim JG
Biometrics; 2006 Mar; 62(1):177-84. PubMed ID: 16542244
[TBL] [Abstract][Full Text] [Related]
16. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
Jiang Z; Song Y; Shou Q; Xia J; Wang W
Trials; 2014 Dec; 15():500. PubMed ID: 25528466
[TBL] [Abstract][Full Text] [Related]
17. Missing radiographic data handling in randomized clinical trials in rheumatoid arthritis.
Huang X; Jiao L; Wei L; Quan H; Teoh L; Koch GG
J Biopharm Stat; 2013; 23(6):1435-52. PubMed ID: 24138441
[TBL] [Abstract][Full Text] [Related]
18. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
Schäfer H; Müller HH
Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
[TBL] [Abstract][Full Text] [Related]
19. Inference methods for saturated models in longitudinal clinical trials with incomplete binary data.
Song JX
Pharm Stat; 2006; 5(4):295-304. PubMed ID: 17128429
[TBL] [Abstract][Full Text] [Related]
20. Multi-regional clinical trial design and consistency assessment of treatment effects.
Quan H; Mao X; Chen J; Shih WJ; Ouyang SP; Zhang J; Zhao PL; Binkowitz B
Stat Med; 2014 Jun; 33(13):2191-205. PubMed ID: 24515845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
